A new app has been launched that provides users with the tools to measure and track longevity while being rewarded in crypto tokens in order to securely contribute medical, biological and lifestyle data to one of the largest longevity DeSci projects.
Longevity research network Rejuve.AI has launched the Rejuve Longevity app that combines AI, cutting-edge research and blockchain technology.
The app analyses users’ demographic, medical, and lifestyle data to give them a biological age estimate, alongside other personalised health insights, helping users understand how to extend their healthy lifespans while ensuring users receive a share of the proceeds gained from the use of their data.
Personalised health insights are built through data gathered using demographic, medical, and lifestyle data from wearables or self-inputted by the users, who then have the option to opt-in to studies and databases, being paid for participation using Rejuve.AI’s RJV crypto token.
The token can be used to make in-app purchases on products such as supplements and DNA tests. The app is designed to not only help users maximise their health, but also provide a deeper dive into data concerning lifespan.
Rejuve Longevity calculates longevity recommendations using over 370 biomarkers, with over 300 present in the AI, one of the largest sets available in today’s market. Alongside this, the app’s systems are built on Bayes Expert, Rejuve.AI’s approach to integrating diverse scientific studies into a holistic understanding of health risks and intervention.
CEO of Rejuve.AI, Jasmine Smith, said: “The Longevity app is one-of-a-kind. While other wellbeing apps monitor one or a few aspects of a person’s health, Rejuve Longevity allows users to earn, discover trusted products and providers, and eventually combine various data types such as genetics, epigenetics and telomeres to get a truly holistic view of their health and longevity progress.
“It also, crucially, allows individuals to take back control of, and benefit from their personal data.
“The level and speed of progress being made in the longevity space is astounding. But that progress shouldn’t be gatekept. Anyone who wants to live a healthier, longer life should have the tools and insight to do so. This is the mission on which we founded Rejuve, and it’s so exciting to see this come to life two years after we penned the initial whitepaper.”
Dr Ben Goertzel, chief AI scientist at Rejuve.AI and CEO of SingularityNET, is one of the AI experts who have contributed to the app’s development, as well as CTO Dr Deborah Duong, an industry leader in AGI research.
Goertzel said: “AI is advancing with remarkable speed, as is the accumulation of valuable biomedical data. There seems little doubt that the application of advanced AI to all this data has tremendous potential to move forward the science of longevity toward deeper understanding and toward powerful therapies for extending human healthspan.
“The pharmaceutical establishment is being distressingly slow at actualising this potential. Their business models and ways of thinking are stuck in a previous era, focused on siloing data and insights in proprietary vaults and attacking one disease at a time in isolation and in a generic way, rather than approaching health in a holistic and personal fashion.
“Rejuve.AI has the modest mission of solving all this, by rolling out the world’s most advanced AI and systems biology modeling technology on decentralised networks leveraging crowdsourced biomedical data, and applying these tools to the reduction and eventual elimination of involuntary human death. It’s a complex and intensive job but someone’s got to do it, our lives are very literally at stake.”
The app is launching both on Android and iOS. The app is free to download, with premium services available by subscription, which will be available later this year.